Not applicableUnknownNCT03353025What this trial is testingStudy on Therapy of Non-invasive ProlactinomaWho this might be right forProlactinoma First Affiliated Hospital, Sun Yat-Sen University 394
Post-approval studies (Phase 4)Looking for participantsNCT07045935What this trial is testingMetabolic Outcomes in Patients With Prolactinomas Under Dopamine Agonist TreatmentWho this might be right forProlactinoma University Hospital, Basel, Switzerland 60
Early research (Phase 1)Ended earlyNCT01088763What this trial is testingGamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell LeukemiaWho this might be right forChildhood Atypical Teratoid/Rhabdoid TumorChildhood Central Nervous System ChoriocarcinomaChildhood Central Nervous System Germinoma+43 more National Cancer Institute (NCI) 129
Not applicableStudy completedNCT01504399What this trial is testingRhinological Outcomes in Endonasal Pituitary SurgeryWho this might be right forPituitary NeoplasmPituitary AdenomaProlactinoma+2 more St. Joseph's Hospital and Medical Center, Phoenix 235
Not applicableUnknownNCT03474601What this trial is testingSeoul National University Pituitary Disease Cohort StudyWho this might be right forPituitary DiseasePituitary IncidentalomaAcromegaly+5 more Seoul National University Hospital 1,600
Not applicableEnded earlyNCT04106531What this trial is testingValidation of a Quality of Life Metric "Prolac-10"Who this might be right forProlactinomaProlactin-Producing Pituitary TumorPituitary Tumor+2 more Ohio State University 8
Not applicableStudy completedNCT00460616What this trial is testingCardiac Valve Complications in Prolactinomas Treated With CabergolineWho this might be right forProlactinomas Federico II University 50
Testing effectiveness (Phase 2)Study completedNCT03038308What this trial is testingTreatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist RopiniroleWho this might be right forHyperprolactinemiaProlactinoma Columbia University 16
Large-scale testing (Phase 3)Looking for participantsNCT07463235What this trial is testingSafety and Potency of a High Cabergoline Dosage in MicroprolactinomasWho this might be right forProlactinomaProlactin Excess University of Sao Paulo General Hospital 70
Not applicableUnknownNCT03400865What this trial is testingCabergoline Combined Hydroxychloroquine/Chloroquine to Treat Resistant ProlactinomasWho this might be right forResistance, DiseaseProlactinoma Zhebao Wu 30
Not applicableLooking for participantsNCT07268183What this trial is testingHow Estrogen Fluctuations Before Diagnosis Affect the Size Prolactin-secreting TumorsWho this might be right forProlactinomaMacroprolactinoma Hospices Civils de Lyon 180
Post-approval studies (Phase 4)UnknownNCT04107480What this trial is testingPRolaCT - Three Prolactinoma RCTsWho this might be right forProlactinomaProlactin-Producing Pituitary Tumor Leiden University Medical Center 880
Early research (Phase 1)Study completedNCT00006368What this trial is testingYttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent CancerWho this might be right forBrain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more Novartis Pharmaceuticals 60
Testing effectiveness (Phase 2)Study completedNCT00697814What this trial is testingClomiphene in Males With Prolactinomas and Persistent HypogonadismWho this might be right forHypogonadotropic HypogonadismProlactinoma Federal University of São Paulo 15